US › Healthcare

Tectonic Therapeutic, Inc. (TECX)

US · Healthcare · Biotechnology

$29.17+4.48%
Last close · 2026-08-04

Latest quarter · ended 2026-03-31

Revenue
$0
Net profit
$-25.2M
Profit YoY
-58.7%
EPS
$-1.34
EPS estimate
$-1.17

EPS came in at -1.34 against a street estimate of -1.17 — a miss of 14.5%.

Key statistics

Market cap
$528.9M
Forward P/E
0.0
P/B
2.30
Book value
$12.24
EPS (TTM)
$-4.46
52-week high
$39.53
52-week low
$14.38
50-day MA
$31.08
200-day MA
$25.44
Beta
0.10

Analyst view

Analysts rate Tectonic Therapeutic, Inc. a strong buy (6 buy, 0 hold, 0 sell out of 6) with an average price target of $78.44.

Shareholding

Insiders
39.34%
Institutions
74.13%

Largest institutional holders

FundStake
FMR Inc14.94%
TCG Crossover Management, LLC6.39%
Aberdeen Group PLC6.06%
BlackRock Inc4.56%
BRAIDWELL LP4.49%
First Light Asset Management, LLC3.44%
Baker Bros Advisors LP3.22%
5AM Venture Management, LLC3.22%

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for Tectonic Therapeutic, Inc. — free to start.

Google PlayApp Store

Other Healthcare companies

Eli Lilly and CompanyJohnson & JohnsonAbbVie IncUnitedHealth Group IncorporatedMerck & Company IncNovartis AG ADRAstraZeneca PLCThermo Fisher Scientific IncNovo Nordisk A/SAmgen IncAbbott LaboratoriesGilead Sciences Inc

Data updated 2026-08-05.